|
Glanbia PLC on Wednesday outlined its growth strategy and associated financial targets from 2026 to 2028 at a capital markets day event, hoping to benefit from fast-growing health and wellness categories. The Kilkenny, Ireland-based sports nutrition company said the CMD will ‘showcase how we are sharpening our focus to achieve our three year growth ambition and capitalise on the significant opportunities ahead.’ Between 2026 and 2028, Glanbia is targeting adjusted earnings per share growth of 7% to 11% on a constant currency basis, operating cash conversion of earnings before interest, tax, depreciation and amortisation of 85% plus, a return on capital employed of 10% to 13%; and a target dividend payout ratio range of 30% to 40%. In the financial year to January 4, 2025, Glanbia reported adjusted EPS of 140.03 euro cents, and a return on capital of 12.4%. At Performance Nutrition, Glanbia forecasts annual organic revenue growth of 5% to 7% and three-year Ebitda margin progression of 250 basis points from 16.9% in the financial year to January 4, 2025. In Health and Nutrition, the firm eyes annual organic revenue growth of 4% to 6% and Ebitda margin range of 17% to 19%. At Dairy Nutrition, Glanbia targets an annual Ebitda range of $150 million to $160 million. ‘We are well positioned to deliver on our ambition to drive growth and shareholder returns,’ said Chief Executive Hugh McGuire. Shares in Glanbia were down 0.7% at €14.00 in London on Wednesday. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
